Apollo Medical Holdings Inc (AMEH) Receives Average Rating of “Buy” from Brokerages

Apollo Medical Holdings Inc (NASDAQ:AMEH) has been assigned an average broker rating score of 2.00 (Buy) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating.

Analysts have set a 12-month consensus target price of $25.00 for the company and are predicting that the company will post $0.08 EPS for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 201 out of 256 based on the ratings given to its competitors.

AMEH has been the subject of several recent research reports. Zacks Investment Research downgraded Apollo Medical from a “buy” rating to a “hold” rating in a report on Wednesday, January 16th. ValuEngine upgraded Apollo Medical from a “hold” rating to a “buy” rating in a report on Tuesday, January 29th.

Institutional investors have recently made changes to their positions in the stock. Great West Life Assurance Co. Can bought a new stake in Apollo Medical during the fourth quarter worth $99,000. SG Americas Securities LLC bought a new stake in Apollo Medical during the first quarter worth $106,000. Strs Ohio grew its holdings in Apollo Medical by 98.6% during the first quarter. Strs Ohio now owns 14,300 shares of the company’s stock worth $261,000 after buying an additional 7,100 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Apollo Medical by 154.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 32,242 shares of the company’s stock worth $640,000 after buying an additional 19,561 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Apollo Medical by 63.4% during the fourth quarter. Bank of New York Mellon Corp now owns 59,862 shares of the company’s stock worth $1,188,000 after buying an additional 23,217 shares in the last quarter. Institutional investors and hedge funds own 6.75% of the company’s stock.

AMEH traded down $0.03 during trading on Monday, hitting $19.90. The company’s stock had a trading volume of 36,060 shares, compared to its average volume of 21,305. Apollo Medical has a twelve month low of $13.01 and a twelve month high of $30.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.40 and a current ratio of 2.40. The firm has a market cap of $715.64 million, a PE ratio of 68.62, a price-to-earnings-growth ratio of 5.86 and a beta of -1.08.

Apollo Medical (NASDAQ:AMEH) last released its quarterly earnings data on Monday, March 18th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.12 by ($0.20). The firm had revenue of $105.46 million for the quarter. Apollo Medical had a net margin of 2.08% and a return on equity of 6.00%. Research analysts predict that Apollo Medical will post 0.34 EPS for the current fiscal year.

About Apollo Medical

Apollo Medical Holdings, Inc, an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read More: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.